Fixed combination of repaglinide and metformin in the management of type 2 diabetes.
about
Development and Validation of a Method for Simultaneous Estimation of Metformin and Sitagliptin in Human Plasma by LC-MS-MS and Its Application in a Bioequivalence Study.Comparison of metformin and repaglinide monotherapy in the treatment of new onset type 2 diabetes mellitus in ChinaA Comparative Review of Waivers Granted in Pediatric Drug Development by FDA and EMA from 2007-2013Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update.
P2860
Fixed combination of repaglinide and metformin in the management of type 2 diabetes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Fixed combination of repaglinide and metformin in the management of type 2 diabetes.
@en
Fixed combination of repaglinide and metformin in the management of type 2 diabetes.
@nl
type
label
Fixed combination of repaglinide and metformin in the management of type 2 diabetes.
@en
Fixed combination of repaglinide and metformin in the management of type 2 diabetes.
@nl
prefLabel
Fixed combination of repaglinide and metformin in the management of type 2 diabetes.
@en
Fixed combination of repaglinide and metformin in the management of type 2 diabetes.
@nl
P2860
P356
P1476
Fixed combination of repaglinide and metformin in the management of type 2 diabetes.
@en
P2093
Robert Moses
P2860
P304
P356
10.2147/DMSOTT.S4436
P577
2009-06-24T00:00:00Z